Stryker Corporation's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Cashflows-From-Financing-Activities" stands at 3.15 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Stryker Corporation's third quarter result of 1.29 Billion USD for the item "Other Cashflows From Financing Activities" represents an increase of 103.30 percent compared to it's second quarter result.
Also, Stryker Corporation's third quarter result of 1.29 Billion USD for the item "Other Cashflows From Financing Activities" represents an increase of 112.32 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Stryker Corporation's third quarter result of 3.15 Billion USD for the item "Other Cashflows From Financing Activities" represents an increase of 27.70 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.919 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.919 Billion United States Dollars.
The 3 year change is 3.21 Billion United States Dollars.
The 5 year change is 3.26 Billion United States Dollars.
The 10 year change is 3.04 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Other Cashflows From Financing Activities | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Other Cashflows From Financing Activities | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Other Cashflows From Financing Activities | 172,241,486,586.05 |
![]() | Danaher Corporation - Other Cashflows From Financing Activities | 162,006,663,168.00 |
![]() | Boston Scientific Corp - Other Cashflows From Financing Activities | 144,567,730,176.00 |